Skip to content

Effect of zinc sulfate in diabetic hemodialysis patients

The effect of zinc sulfate on serum copeptin, C-Reactive protein, insulin resistance and nutritional status in diabetic hemodialysis patients

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20190806044461N1
Enrollment
40
Registered
2019-08-23
Start date
2019-08-23
Completion date
Unknown
Last updated
2019-10-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic kidney disease. Chronic kidney disease, stage 5

Interventions

Intervention 1: Intervention group: The zinc-supplementation group(n=20) will receive a 220-mg zinc sulfate capsule(containing 50 mg zinc) manufactured by Alhavi Pharmaceutical Company (Tehran, Iran
for 8 weeks. Intervention 2: Control group:The control-group(n=20) will receive a placebo capsule(220-mg corn starch), for 8 weeks.

Sponsors

Zahedan University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
15 Years to 70 Years

Inclusion criteria

Inclusion criteria: Diabetic hemodialysis patients(Pass at least 6 months from hemodialysis); Age:15-70; Not having inflammatory diseases affecting on serum inflammatory markers; One month before the study began no supplements containing antioxidants,zinc supplement,vitamins E and C supplements; Steroid and non-steroidal anti-inflammatory drugs should not be used.

Exclusion criteria

Exclusion criteria: If the patients have been taking antibiotics for the past month and with infectious or feverish disease. Also Diseases affecting serum copeptin like severe cardiovascular disease, Hypothyroidism ,hyperthyroidism and sepsis are not included in this study.

Design outcomes

Primary

MeasureTime frame
Serum copeptin. Timepoint: Before and after 8-week intervention. Method of measurement: It measured by ELISA method with standard kit.;Serum insulin. Timepoint: Before and after 8-week intervention. Method of measurement: It measured by ELISA method with standard kit.;C-Reactive-Protein. Timepoint: Before and after 8-week intervention. Method of measurement: It measured by ELISA method with standard kit.;Nutritional status. Timepoint: Before and after 8-week intervention. Method of measurement: Food Frequency Questionnaire.

Secondary

MeasureTime frame
Insulin resistance. Timepoint: Before and after 8-week intervention. Method of measurement: Homeostasis model assessment measuring insulin resistance.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactRazieh Hosseini

Zahedan University of Medical Sciences

razieh.hosseini7759@gmail.com+98 71 4252 0479

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 23, 2026